The Human Phospholipase B-II Precursor (HPLBII-P) in Urine as a Novel Biomarker of Increased Glomerular Production or Permeability in Diabetes Mellitus?

Shengyuan Xu, Anders Larsson, Lars Lind, Cecilia Lindskog, Johan Ärnlöv, Per Venge

Abstract read

In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shengyuan XuDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, SE-751 85 Uppsala, Sweden.

Anders LarssonDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, SE-751 85 Uppsala, Sweden.ORCID 0000-0003-3161-0402

Lars LindDepartment of Medical Sciences, Internal Medicine, Uppsala University, SE-751 85 Uppsala, Sweden.

Cecilia LindskogDepartment of Immunology, Genetics and Pathology, Uppsala University, SE-751 83 Uppsala, Sweden.ORCID 0000-0001-5611-1015

Johan ÄrnlövDivision of Family Medicine and Primary Care, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, SE-141 52 Huddinge, Sweden.

Per VengeDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, SE-751 85 Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkernephropathypodocyte

Identifiers

PMID38731158

DOI10.3390/jcm13092629

PMCPMC11084184

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.